S
Stephen J. Wort
Researcher at National Institutes of Health
Publications - 84
Citations - 3236
Stephen J. Wort is an academic researcher from National Institutes of Health. The author has contributed to research in topics: Pulmonary hypertension & Medicine. The author has an hindex of 25, co-authored 65 publications receiving 2548 citations. Previous affiliations of Stephen J. Wort include Imperial College London.
Papers
More filters
Journal ArticleDOI
Improved Survival Among Patients With Eisenmenger Syndrome Receiving Advanced Therapy for Pulmonary Arterial Hypertension
Konstantinos Dimopoulos,Ryo Inuzuka,Sara Goletto,Georgios Giannakoulas,Lorna Swan,Stephen J. Wort,Michael A. Gatzoulis +6 more
TL;DR: Survival benefits should be considered together with improved hemodynamics and functional class when decisions are made about AT in this population of adults with Eisenmenger syndrome, and patients on AT were at a significantly lower risk of death.
Journal ArticleDOI
Pulmonary vascular and right ventricular dysfunction in adult critical care: current and emerging options for management: a systematic literature review
TL;DR: Although some recommendations can be made to guide the critical care management of pulmonary vascular and right ventricular dysfunction, within the limitations of this review and the GRADE methodology, the quality of the evidence base is generally low, and further high-quality research is needed.
Journal ArticleDOI
Plasma DNA concentration as a predictor of mortality and sepsis in critically ill patients
TL;DR: Plasma DNA may be a useful prognostic marker of mortality and sepsis in intensive care patients and is found to be significantly higher in patients who died in the ICU.
Journal ArticleDOI
Circulating Endothelial Progenitor Cells in Patients With Eisenmenger Syndrome and Idiopathic Pulmonary Arterial Hypertension
Gerhard-Paul Diller,Sven van Eijl,Darlington O. Okonko,Luke Howard,Omar Ali,Thomas Thum,Stephen J. Wort,Elisabeth Bédard,J. Simon R. Gibbs,Johann Bauersachs,Adrian J. Hobbs,Martin R. Wilkins,Michael A. Gatzoulis,John Wharton +13 more
TL;DR: Within the idiopathic PAH population, treatment with the phosphodiesterase inhibitor sildenafil was associated with a dose-dependent rise in EPC numbers, resulting in levels consistently above those found with other therapies.
Journal ArticleDOI
Detection of Pulmonary Hypertension with Multidetector CT and Echocardiography Alone and in Combination
Anand Devaraj,Athol U. Wells,Mark G. Meister,Tamera J. Corte,Stephen J. Wort,David M. Hansell +5 more
TL;DR: A combination of CT and echocardiographic markers of PH is more closely related to mPAP than either test in isolation.